Pembrolizumab for Esophageal Carcinoma User Reviews
Brand names: Keytruda
Pembrolizumab has an average rating of 3.2 out of 10 from a total of 4 reviews for the treatment of Esophageal Carcinoma. 25% of reviewers reported a positive experience, while 75% reported a negative experience.
- KMAX
- Taken for 1 to 6 months
- December 5, 2020
Keytruda (pembrolizumab) "My husband's cancer was held at bay for over a year with chemotherapy and radiation. When he'd exhausted these treatments, Keytruda was recommended. After one month of this medicine, his cancer exploded throughout his body, especially his bones. The doctor admitted to us afterwards that this is what happens sometimes with this medication. He died just months after his first Keytruda dose."
- Frankjw
- Taken for 1 to 2 years
- May 23, 2021
Keytruda (pembrolizumab) "I was diagnosed with EC in Feb 2019. I did the Flot4 treatment for 3 months then I had the ivor Lewis surgery. I was offered keytruda after surgery but chose to not do this. At the time after the surgery I had no more cancer but 9 months later the cancer metastasized to my brain which is extremely rare. After my surgery to remove that tumor and 3 quick rounds of radiation I chose to do keytruda. I believe in my heart of hearts if I went on it after my ivor Lewis surgery then it would not had metastasized. I have been using it now for just over a year, with very few side effects. My advise though is to exercise so the fatigue does not take over. The treatments are simple and only last 30 minutes. I would not use it as a primary treatment for EC. Best is surgery then if offered keytruda."
Frequently asked questions
- Pembrolizumab vs. nivolumab: How do they compare?
- How are Inlyta and Keytruda used in kidney cancer?
- What type of cancer is pembrolizumab used for?
- How does pembrolizumab affect the immune system?
- Anonymous
- Taken for 1 to 6 months
- September 26, 2021
Keytruda (pembrolizumab) "Dad had battled the cancer for a year with chemo and radiation. He had improved quite a bit. The doctor started him on keytruda and it was downhill from there. Within months he was dead. This drug needs to be pulled off the market."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about pembrolizumab
- Check interactions
- Compare alternatives
- Reviews (227)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Keytruda (pembrolizumab) "Maybe it works for some but I knew after my husbands first dose of Keytruda something was wrong. I don't like new drugs for this reason they don’t test them enough and are hiding the effects of this drug. My husband was doing good until he took this drug. His cancer spread like wildfire after several doses of this drug. After 8 years of fighting esophageal cancer and it being fairly stable...he started this drug he now has adrenal cancer, cancer in his kidneys and brain cancer that will likely finish him off and guess what the esophageal cancer is still fairly stable. If we had stuck with traditional chemo I believe my husband would still be healthy. He had one problem after another from this medicine. I thought I did a good job checking this out. The Keytruda makers have so many ads and websites you can’t get to the reviews from real patients. Beware the side effects may worse then the help. Really know what your doing"